Multidisciplinary management of hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 43, Issue 12, 1996, Pages 1611-1619

  Lygidakis, N J ^a,b   Tsiliakos, S ^a  

^a Athineon Hospital   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; GELFOAM; HOMATROPINE METHYL BROMIDE; IODINATED POPPYSEED OIL; MEGLUMINE DIATRIZOATE; MITOMYCIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDEMA; FEMALE; FEVER; HUMAN; HYPOTENSION; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; FEMALE; HEPATECTOMY; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030476004     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tanaka Akira, Taisuke Morimoto, Nobuhiro Ozaki, et al. Extension of surgical indication for advanced hepatocellular carcinoma: Is it possible to prolong life span or improve quality of life?.Hepato-Gastroentrol 1996; 43: 1172-1181.
2. Yamasaki Takahiro, Fumie Kurokawa, Akiro Kato, et al. Clinicopathological Features of Early Hepatocellular Carcinoma.Hepato-Gastroentrol 1996; 43: 926-931.
3. Tanaka Akira, Taisuke Morimoto, Yoshio Yamaoka. Implications of Surgical Treatment for Advanced Hepatocellular Carcinoma with Tumor Thrombi in the Portal Vein Hepato-Gastroentrol 1996; 43: 637-643.
4. Jan Yi-Yin, Long-Bin Jeng, Tsaun-Long Hwang, et al. Factors Influencing Survival After Hepatectomy for Peripheral Cholangiocarcinoma.Hepato-Gastroentrol 1996; 43: 614-619.
5. Okusaka Takuji, Shuichi Okada, Haruhiko Nose, et al. The Prognosis Of Patients With Hepatocellular Carcinoma of Multicentric Origin.Hepato-Gastroentrol 1996; 43: 919-925.
6. Shuto Taichi, Hiroaki Kinoshita, Kazuhiro Hirohashi, et al. Indications for, and Effectiveness of, Second Hepatic Resection for Recurrent Hepatocellular Carcinoma.Hepato-Gastroentrol 199?; : 932-937.
7. Lygidakis NJ, Stringaris K. Locoregional Immuno-Chemotherapy Transplenic and Transtumoral in vivo Immunostimulation. Hepatogastroenterol 1996; 43: 440-447.
8. Nimura, et al. Annals of Surgery 1996; 223
9. Makuuchi, et al. Surgery 1990; 107: 521
10. Harada Toshiro, Katsuichi Matsuo, Takato Inoue, et al. Multimodal Treatment of Stage IVa Hepatocellular Carcinoma.Hepato-Gastroentrol 1996; 43: 1154-1158.
11. Ishii Hiroshi, Shuichi Okada, Tosiya Sato, et al. Effect of Percutaneous Ethanol Injection for Postoperative Recurrence of Hepatocellular Carcinoma in Combination with Transcatheter Arterial Embolization..Hepato-Gastroentrol 1996; 43: 644-650.
12. Ishii Hiroshi, Shuichi Okada, Haruhiko Nose, et al. Predictive Factors for Recurrence after Percutaneous Ethanol Injection for Solitary Hepatocellular Carcinoma.Hepato-Gastroentrol 1996; 43: 938-943.
13. Shimada Mitsuo, Kenji Takenaka, Naoyuki Kawahara, et al. Chemosensitivity in Primary Liver Cancers: Evaluation of the Correlation between Chemosensitivity and Clinicopathological Factors.Hepato-Gastroentrol 1996; 43: 1159-1164.
14. Baars JW, Wagstaff J, Boven E et al. Phase I study on the sequential administration of recombinant human INF-y and recombinant Human IL2 in patients with metastatic solid tumors. Joumal of National Cancer Institute. 83:1408-1410, 1991.
15. Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional versus systemic continuous 5-Fluourodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann. Surg. 1987, 206: 685-93
16. Fennelly D, Kelsen D. The Role of Chemotherapy in the Treatment of Adenocarcinoma of the pancreas. Hepato-Gastroenterol. 1996; 43:356-362.
17. Lygidakis NJ, Papadopoulou P. Pancreatic Head Carcinoma: Is Pancreatic Resection Indicated for Patients with Stage III Pancreatic Duct Cancer? Hepatogastroenterol. 1995;42: 587-596.
18. Lygidakis NJ, Ziras N, Kyparidou E, Parissis J, et al. Combined Immuno-Pharmaceutical Therapy of Patients with Unresectable Pancreatic Carcinoma. Hepato-Gastroenterol 1995; 42: 1039-1052.
19. Ohigashi H, Ishikawa O, Imaoka S, Sasaki Y, et al. A New Method of Intra-Arterial Regional Chemotherapy with more selective Drug Delivery for Locally Advanced Pancreatic Cancer. HepatoGastroenterol. 1996; 43:338-345.